Research Collaborations TGen actively partners with leading research institutions and healthcare providers such as Dell Technologies, Mayo Clinic, and Deepcell, indicating a strong openness to technological integrations and data management solutions.

Innovative Technologies The company uses advanced tech stacks like AI-driven imaging platforms and collaborates on genetic mouse models, providing opportunities for sales of data analysis tools, AI software, and biotech infrastructure.

Financial Growth Potential With a funding of $14M and revenues between $1M and $10M, TGen demonstrates financial stability and growth potential, making it a viable partner for scalable research and technology investments.

Research Focus TGen’s engagement in cutting-edge areas like minimal residual disease testing and rare genetic disease models signals opportunities in clinical diagnostics, laboratory equipment, and research reagents.

Strategic Industry Position As part of City of Hope with collaborations across top-tier medical institutions, TGen is strategically positioned at the intersection of biotech research and clinical application, ideal for targeted sales of biotech solutions, data management platforms, and medical research tools.